FLUARIX QUADRIVALENT Rx
Generic Name and Formulations:
Quadrivalent inactivated "split virus" influenza vaccine (types A and B); contains a total of 60mcg hemagglutinin per 0.5mL dose; formulation changes annually; susp for IM inj; may contain trace amounts of hydrocortisone, gentamicin, others; preservative-free.
Indications for FLUARIX QUADRIVALENT:
Adults and Children:
<3yrs: not established. Each dose is 0.5mL by IM inj once in the deltoid. 3–8yrs (previously unvaccinated): 2 doses/season, give at least 4 weeks apart. 3–8yrs (vaccinated in a previous season): 1 or 2 doses/season (depending on vaccination history as per annual ACIP recommendation); if 2 doses/season; give at least 4 weeks apart. ≥9yrs: 1 dose/season.
Allergy to egg protein. Life-threatening reaction to any previous flu vaccine.
Use current formulation only. Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Bleeding disorders. Immunosuppressed. Risk of sycope with injectable vaccines. Have epinephrine inj (1:1000) available. Latex allergy. Pregnancy (Cat.B). Nursing mothers.
Concomitant vaccines: insufficient data (see full labeling). Immunosuppressants (eg, radiation, chemotherapy, high-dose steroids): may result in suboptimal response.
Local reactions (eg, redness, swelling, pain), muscle aches, fatigue, headache, arthralgias, GI symptoms, shivering, fever; children: irritability, loss of appetite, drowsiness.
Single-dose prefilled Tip-Lok syringes (0.5mL)—10